I
IDXG
Interpace Biosciences Inc
6.00
0.000.00%Closed15:29 10/07 EDT
OPEN/PREV CLOSE--/6.00
TODAY RANGE-
VOL--
MARKET CAP33.24M
52 WEEK RANGE4.028-11.90
AVG VOL (3M)943
% TURNOVER0%
TURNOVER--
P/E (TTM)1.360
% RANGE--
EPS(TTM)4.413
P/E(FORWARD)1.302
P/B1.430
BVPS4.196
DIVIDEND--
P/S0.137
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.93M
SHARES OUTSTANDING5.54M
NEXT EARNINGS11/10-11/16
FREE FLOAT488.61K
LOT SIZE100
EX-DATE08/27/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/26 02:40
U.S. IPO Weekly Recap: Postponed Deals Put Damper On Fall IPO Market
TipRanks·08/26 20:50
Interpace Biosciences announces 1-for-5 reverse split for Nasdaq uplisting
TipRanks·08/21 10:29
Interpace Diagnostics Shareholders Approve Governance and Equity Plans
Seeking Alpha·08/10 21:02
Interpace Biosciences GAAP EPS of $0.01, revenue of $9.1M
Seeking Alpha·05/12 20:47
Interpace Biosciences GAAP EPS of $0.03, revenue of $9.03M
Seeking Alpha·03/30 20:05
Interpace Biosciences GAAP EPS of $0.82, revenue of $9.22M
TipRanks·01/20 14:40
Interpace Diagnostics Guides 2026 Growth After Balance Sheet Cleanup
TipRanks·01/20 14:12
Interpace Biosciences sees FY25 revenue $38M-$39M
TipRanks·01/20 14:11
Interpace Biosciences sees FY26 revenue $40M
TipRanks·01/20 14:11
Interpace Biosciences announces preferred stock conversion
TipRanks·01/20 14:10
Interpace Biosciences to seek uplisting to Nasdaq Stock Market
TipRanks·12/03/2025 21:34
Interpace Biosciences Repays Loan Early for Growth
Seeking Alpha·11/13/2025 05:54
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
Same Industry
Name/Symbol
Change%
Price